Cargando…
Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway
ABCC6, belonging to sub-family C of ATP-binding cassette transporter, is an ATP-dependent transporter mainly present in the basolateral plasma membrane of hepatic and kidney cells. Although the substrates transported are still uncertain, ABCC6 has been shown to promote ATP release. The extracellular...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349786/ https://www.ncbi.nlm.nih.gov/pubmed/32517079 http://dx.doi.org/10.3390/cells9061410 |
_version_ | 1783557135506866176 |
---|---|
author | Ostuni, Angela Carmosino, Monica Miglionico, Rocchina Abruzzese, Vittorio Martinelli, Fabio Russo, Daniela Laurenzana, Ilaria Petillo, Agata Bisaccia, Faustino |
author_facet | Ostuni, Angela Carmosino, Monica Miglionico, Rocchina Abruzzese, Vittorio Martinelli, Fabio Russo, Daniela Laurenzana, Ilaria Petillo, Agata Bisaccia, Faustino |
author_sort | Ostuni, Angela |
collection | PubMed |
description | ABCC6, belonging to sub-family C of ATP-binding cassette transporter, is an ATP-dependent transporter mainly present in the basolateral plasma membrane of hepatic and kidney cells. Although the substrates transported are still uncertain, ABCC6 has been shown to promote ATP release. The extracellular ATP and its derivatives di- and mono-nucleotides and adenosine by acting on specific receptors activate the so-called purinergic pathway, which in turn controls relevant cellular functions such as cell immunity, inflammation, and cancer. Here, we analyzed the effect of Abcc6 knockdown and probenecid-induced ABCC6 inhibition on cell cycle, cytoskeleton, and motility of HepG2 cells. Gene and protein expression were evaluated by quantitative Reverse Transcription PCR (RT-qPCR) and western blot, respectively. Cellular cycle analysis was evaluated by flow cytometry. Actin cytoskeleton dynamics was evaluated by laser confocal microscopy using fluorophore-conjugated phalloidin. Cell motility was analyzed by in vitro wound-healing migration assay. Cell migration is reduced both in Abcc6 knockdown HepG2 cells and in probenecid treated HepG2 cells by interfering with the extracellular reserve of ATP. Therefore, ABCC6 could contribute to cytoskeleton rearrangements and cell motility through purinergic signaling. Altogether, our findings shed light on a new role of the ABCC6 transporter in HepG2 cells and suggest that its inhibitor/s could be considered potential anti-metastatic drugs. |
format | Online Article Text |
id | pubmed-7349786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73497862020-07-15 Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway Ostuni, Angela Carmosino, Monica Miglionico, Rocchina Abruzzese, Vittorio Martinelli, Fabio Russo, Daniela Laurenzana, Ilaria Petillo, Agata Bisaccia, Faustino Cells Article ABCC6, belonging to sub-family C of ATP-binding cassette transporter, is an ATP-dependent transporter mainly present in the basolateral plasma membrane of hepatic and kidney cells. Although the substrates transported are still uncertain, ABCC6 has been shown to promote ATP release. The extracellular ATP and its derivatives di- and mono-nucleotides and adenosine by acting on specific receptors activate the so-called purinergic pathway, which in turn controls relevant cellular functions such as cell immunity, inflammation, and cancer. Here, we analyzed the effect of Abcc6 knockdown and probenecid-induced ABCC6 inhibition on cell cycle, cytoskeleton, and motility of HepG2 cells. Gene and protein expression were evaluated by quantitative Reverse Transcription PCR (RT-qPCR) and western blot, respectively. Cellular cycle analysis was evaluated by flow cytometry. Actin cytoskeleton dynamics was evaluated by laser confocal microscopy using fluorophore-conjugated phalloidin. Cell motility was analyzed by in vitro wound-healing migration assay. Cell migration is reduced both in Abcc6 knockdown HepG2 cells and in probenecid treated HepG2 cells by interfering with the extracellular reserve of ATP. Therefore, ABCC6 could contribute to cytoskeleton rearrangements and cell motility through purinergic signaling. Altogether, our findings shed light on a new role of the ABCC6 transporter in HepG2 cells and suggest that its inhibitor/s could be considered potential anti-metastatic drugs. MDPI 2020-06-05 /pmc/articles/PMC7349786/ /pubmed/32517079 http://dx.doi.org/10.3390/cells9061410 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ostuni, Angela Carmosino, Monica Miglionico, Rocchina Abruzzese, Vittorio Martinelli, Fabio Russo, Daniela Laurenzana, Ilaria Petillo, Agata Bisaccia, Faustino Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway |
title | Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway |
title_full | Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway |
title_fullStr | Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway |
title_full_unstemmed | Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway |
title_short | Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway |
title_sort | inhibition of abcc6 transporter modifies cytoskeleton and reduces motility of hepg2 cells via purinergic pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349786/ https://www.ncbi.nlm.nih.gov/pubmed/32517079 http://dx.doi.org/10.3390/cells9061410 |
work_keys_str_mv | AT ostuniangela inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway AT carmosinomonica inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway AT miglionicorocchina inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway AT abruzzesevittorio inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway AT martinellifabio inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway AT russodaniela inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway AT laurenzanailaria inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway AT petilloagata inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway AT bisacciafaustino inhibitionofabcc6transportermodifiescytoskeletonandreducesmotilityofhepg2cellsviapurinergicpathway |